High-density lipoprotein-cholesterol and triglyceride levels and their prognosis in critically ill septic patients
Authors:
Open Access
- 9 June 2026
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Critical Care Medicine
- Vol. 15 (2) , 117211
Abstract
BACKGROUND Lipoproteins, particularly high-density lipoproteins (HDLs), have the ability to bind to lipopolysaccharides, the primary component of the extracellular membrane of gram-negative bacteria, as well as to lipoteichoic acid, an immunostimulant derived from gram-positive bacteria. Triglyceride (TG) levels are also indicators of acute inflammation. Altered levels of both are prevalent in sepsis, rendering them potential biomarkers that are cost-effective and readily applicable in clinical practice for monitoring these patients. It is crucial to compare the levels of these molecules with those of more traditional and costly biomarkers. AIM To evaluate the association between HDL and TG levels in the diagnosis of sepsis (HDL/TG day 1), as well as the association between the ratio of HDL and TG levels on days 3 and day 1 (HDL/TG ratio) and 28-day mortality in patients with sepsis. We also compared the serum levels of HDL and TG levels with traditional inflammatory markers used in the prognostic assessment of sepsis: Interleukin (IL)-1β, IL-6, and IL-10, measured serially in patients with sepsis. METHODS This was a prospective cohort study. Adult patients (> 18 years of age) admitted to the intensive care unit with sepsis and receiving vasopressors were included. We recorded the epidemiological and clinical characteristics, as well as the severity scores, at the time of sepsis diagnosis and on day 3 of sepsis management. We measured HDL 1, TG 1, IL-1β, IL-6, IL-10, and C-reactive protein (CRP) levels upon the diagnosis of sepsis and on day 3 and calculated the HDL and TG ratios. The main outcome was 28-days mortality. RESULTS Seventy-five patients had measurements on day 1 (male:female ratio 58%:42%), and 50 patients had measurements on day 3. Patients who died had lower HDL 1 [9 mg/dL (5-17) vs 18.5 mg/dL (8-31), P = 0.02] but did not have lower TG levels on day 1 [142 mg/dL (83-224) vs 148 mg/dL (97-196), P = 0.97]. Additionally, patients who succumbed exhibited a non-statistically significant increase in the HDL ratio [1.26 (1-1.79) vs 1.16 (1.01-1.39), P = 0.29] and a non-statistically significant increase in the TG ratio [1.16 (0.85-1.36) vs 1.02 (0.67-1.36), P = 0.69]. HDL levels on day 1 were negatively associated with IL-10 on day 1 (Pearson’s r = -0.37; P < 0.01) and with CRP on day 1 (Pearson’s r = -0.52; P < 0.01), but not with IL-6 (P = 0.19) or IL-1β (P = 0.62). TG 1 was positively associated with CRP on day 1 (Pearson’s r = 0.57, P < 0.01) but not with IL-6 (P = 0.21), IL-10 (P = 0.12), or IL-1β (P = 0.09). CONCLUSION HDL levels are a promising biomarker for the evaluation of patients with sepsis, and their levels correlate with traditional biomarkers in this field, such as CRP and IL-10. Further multicenter studies with larger cohorts should be conducted to confirm or refute this hypothesis.Keywords
This publication has 24 references indexed in Scilit:
- Long-term Host Immune Response Trajectories Among Hospitalized Patients With SepsisJAMA Network Open, 2019
- Lipid profile associated with the systemic inflammatory response syndrome and sepsis in critically ill patientsNutrition, 2018
- High-Density Lipoprotein, Mean Platelet Volume, and Uric Acid as Biomarkers for Outcomes in Patients With Sepsis: An Observational StudyJournal of Intensive Care Medicine, 2018
- Low HDL levels in sepsis versus trauma patients in intensive care unitAnnals of Intensive Care, 2017
- Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsisJournal of Critical Care, 2017
- SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysisCritical Care, 2017
- Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admissionJournal of Critical Care, 2015
- High-Density Lipoproteins in Sepsis and Septic Shock: Metabolism, Actions, and Therapeutic ApplicationsShock, 2004
- Lipoprotein metabolism in patients with severe sepsisCritical Care Medicine, 2003
- Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins.Journal of Lipid Research, 1989